September 27, 2022
September 27, 2022
Categories

Media Advisory: Journal of Clinical Oncology publishes outcomes from the practice-changing DREAMseq trial in patients with advanced melanoma

Do you like it?
Read more
September 8, 2022
September 8, 2022
Categories

Press Release: ECOG-ACRIN completes the first randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

Do you like it?
Read more
July 14, 2022
July 14, 2022
Categories

Media Advisory: Blood publishes long-term outcomes of patients with CLL in the practice-changing E1912 trial

Do you like it?
Read more
May 27, 2022
May 27, 2022
Categories

Press Release: ECOG-ACRIN research highlights at ASCO 2022

Do you like it?
Read more
May 17, 2022
May 17, 2022
Categories

Media Advisory: ECOG-ACRIN data at ASCO will showcase the Group’s robust research portfolio

Do you like it?
Read more
March 25, 2022
March 25, 2022
Categories

Press Release: Enrollment in TMIST breast cancer screening trial surpasses halfway mark; recruitment of women from diverse backgrounds is key to success

Do you like it?
Read more
March 16, 2022
March 16, 2022
Categories

Press Release: ECOG-ACRIN opens a new NCI-MATCH treatment arm for dMMR and LAG-3-positive cancers as it continues to locate patients with BRAF mutations

Do you like it?
Read more
December 21, 2021
December 21, 2021
Categories

Press Release: A new post-surgery approach for treating HPV-related throat cancer uses less radiation safely and spares the majority of patients from chemotherapy

Do you like it?
Read more
November 16, 2021
November 16, 2021
Categories

Press Release: Practice-changing trial results for advanced skin cancer

Do you like it?
Read more
Load more
ECOG-ACRIN Cancer Research Group